Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-05-28FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Losartan Potassium 25 mg (generic) by Strides Pharma Science Limited, enabling the generic p…
-
FDA approval · 2013-05-28FDA Approved: METOPROLOL TARTRATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' metoprolol tartrate as an original generic product (ANDA 202871).
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Effect of Green Tea in Obese Pre-hypertensive Women [NA]
A completed clinical trial evaluated the effects of green tea in obese pre-hypertensive women. The study was sponsored by Rio de Janeiro Sta…
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) [NA]
This clinical trial update describes a multicenter study evaluating the timing of dosing for a combined ARB and calcium channel blocker regi…
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: Sleep Heart Health Study (SHHS) Data Coordinating Center
This update notes the Sleep Heart Health Study Data Coordinating Center sponsored by Johns Hopkins Bloomberg School of Public Health has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2013-05-16FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Eplerenone by Mylan Pharmaceuticals, typically indicating labeling updates.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) [Phase 4]
Phase 4 trial evaluating the efficacy and safety of nebivolol in younger adults (18-54) with hypertension has completed and posted results.
-
EMA guidance · 2013-05-16World Hypertension Day: 17 May 2013
EMA information release coinciding with World Hypertension Day highlighting awareness and general information about hypertension management.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension
This document provides an update on a completed clinical trial investigating the relationship between obstructive sleep apnea and endothelia…
-
FDA approval · 2013-05-14FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, granting approval of an additional generic carvedi…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients [Phase 4]
A Phase 4 randomized, double-blind, active-control trial compares telmisartan, candesartan, and amlodipine, each alone or with metformin, in…
-
CLINICAL_TRIALS withdrawal · 2013-05-14Clinical Trial Update: Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension
Pfizer-sponsored clinical trial evaluating spironolactone plus hydroflumethiazide for hypertension in Filipino patients has been withdrawn.
-
FDA approval · 2013-05-07FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for carvedilol from Dr. Reddy's Laboratories Limited (ANDA) to modify or update the approved product…
-
FDA approval · 2013-05-07FDA Approved: CARVEDILOL — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for carvedilol submitted by Sandoz Inc.
-
FDA approval · 2013-05-06FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tribenzor, a fixed-dose combination of olmesartan medoxomil, amlodipine besylate, and hydrochlor…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters [NA]
A completed trial comparing ketofol (ketamine-propofol admixture) with propofol as induction agents and their effects on hemodynamic paramet…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress [Phase 2, Phase 3]
Phase 2/3 trial evaluating pterostilbene effects on cholesterol, blood pressure, and oxidative stress; study completed with results posted i…
-
FDA approval · 2013-05-03FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Strides Pharma Science Limited)
FDA approves Strides Pharma Science Limited's hydralazine hydrochloride as an original ANDA generic product for hypertension.
-
FDA approval · 2013-05-03FDA Approved: CANDESARTAN CILEXETIL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for candesartan cilexetil (generic) by Mylan Pharmaceuticals Inc., authorizing the marketing of a gene…
-
FDA approval · 2013-05-02FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter's supplemental NDA for Cardene IV (nicardipine hydrochloride), authorizing changes to the approved intravenous product u…
-
FDA approval · 2013-05-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate under ANDA 076846.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance [Phase 4]
A Phase 4 trial comparing valsartan with amlodipine in hypertensive patients with glucose intolerance has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke [NA]
A completed clinical trial evaluating the acute cardiovascular effects of passive vibration in individuals with stroke, including participan…
-
FDA approval · 2013-04-29FDA Approved: METOPROLOL — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter's generic metoprolol tartrate (METOPROLOL TARTRATE) as an Original Application. The approval supports the generic produc…
-
FDA approval · 2013-04-29FDA Approved: QUINAPRIL — Original Application (Aurobindo Pharma Limited)
FDA approves the original generic application for quinapril hydrochloride (quinapril HCl) from Aurobindo Pharma Limited.